Roche Pharmaceutical Development and Sales Overview

YTD Sep 2022: Regional sales development -1% -1% 0% +7% +6% +2% +1% Pharma Division 0% -427 +838 780 353 Roche -239 +236 +18 -73 United States Europe Intl. Chugai (Japan) Dia Division Group Fx1 Group CER CHF Absolute values in CHFm at Constant Exchange Rates (avg full year 2021); 1 avg. full year 2021 to avg YTD September 2022 fx impact 46 46

View entire presentation